We are live on ! Find out more
RALS

ProShares RAFI Long/Short

Delisted

RALS was delisted on the 2nd of May, 2022.

11 hedge funds and large institutions have $2.73M invested in ProShares RAFI Long/Short in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 1211 (-1)

20% less capital invested

Capital invested by funds: $3.41M → $2.73M (-$675K)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

RALS Hedge Fund Activity: Q4 2019 in Review

11 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in ProShares RAFI Long/Short (RALS) for Q4 2019, worth a combined $2.73M — down 20% from $3.41M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of RALS and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.

The largest buyer was ProShare Advisors, adding an estimated $143K. The largest seller was Axa, exiting entirely with an estimated $1.33M sold.

  • 11 institutional investors held ProShares RAFI Long/Short (RALS) as of Q4 2019, down from 12 in Q3 2019.
  • Funds reported $2.73M of ProShares RAFI Long/Short stock for Q4 2019, down 20% quarter-over-quarter.
  • 1 fund opened new ProShares RAFI Long/Short positions in Q4 2019 and 2 closed out, a net change of -1 holder.
  • The largest ProShares RAFI Long/Short buyer in Q4 2019 was ProShare Advisors, an estimated $143K added.
  • The largest ProShares RAFI Long/Short seller in Q4 2019 was Axa, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2019.